Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Melanocortins as Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives.
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
A nurse-led mental health service for people with multiple sclerosis.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Early detection of MS treatment complication may improve survival
Tenascins and inflammation in disorders of the nervous system.
Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Feedforward postural control in individuals with multiple sclerosis during load release.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Practical medical applications of quantitative MR relaxometry.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35-55-Induced Experimental Autoimmune Encephalomyelitis.
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
The nervous system's potential role in multiple sclerosis associated bone loss.
Pages
« first
‹ previous
…
223
224
225
226
227
228
229
230
231
…
next ›
last »